U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.
Full record GDS5386

Histone deacetylase inhibitor and chemotherapy combined effect on Raji Burkitt's lymphoma cell line

Analysis of Raji Burkitt's lymphoma (BL) cell line treated with histone deacetylase inhibitor HDACi (sodium butyrate, NaB) or chemotherapy (VP-16) or both for 24 hours. Results provide insight into the molecular effects of combined HDACi/VP-16 therapy of this aggressive B-cell lymphoma.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 4 protocol sets
Platform:
GPL4133
Series:
GSE48399
8 Samples
Download data: TXT
DataSet
Accession:
GDS5386
ID:
5386
2.

Histone Deacetylase Inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leading to up regulation of micro RNA-143, -145 and -101

(Submitter supplied) In this study we analyzed gene expression profiles in a well-characterized BL cell line upon treatment with HDACi combined with chemotherapy. The impact on gene expression regulation was broader when HDACi was combined with chemotherapy, than when either therapy was used alone. As expected, treatment interfered in the regulation of cell cycle progression and enhanced cell death. Noteworthy was the effect on members of p53 signaling pathway. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS5386
Platform:
GPL4133
8 Samples
Download data: TXT
Series
Accession:
GSE48399
ID:
200048399
3.

Gene expression profile of the human leukemia cell line Reh after treatment with bortezomib, valproic acid or a combination of both.

(Submitter supplied) New therapy options are required for relapsed B-cell precursor ALL patients in order to improve survival and reduce adverse acute and late effects. We observed a synergistic anti-leukemic activity of concomitant treatment with bortezomib and valproic acid in BCP-ALL cells. In this experiment we aimed to identify the pathways modulated after concomitant treatment with bortezomib and valproic acid.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13607
4 Samples
Download data: TXT
Series
Accession:
GSE41951
ID:
200041951
4.

miRNA expression of lymphoma cell lines with or without HDAC inhibitor treatment

(Submitter supplied) Various types of HDAC inhibitor are now planned or on going to use against non-Hodgkin’s lymphoma including CTCL. However there is a lack of molecular based evidence not only for which HDACi might be effective to use against advanced CTCL but also for which genes might be pivotal target gene(s) of HDACi. To investigate expression changes of miRNAs by HDACis, we conducted miRNA microarray by using CTCL cell lines.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL18402
12 Samples
Download data: TXT
Series
Accession:
GSE81190
ID:
200081190
5.

Small-RNA expression in normal and malignant mature B cells

(Submitter supplied) Small-RNA profiles were generated for normal mature germinal center (GC) B cells and GC-derived lymphomas.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL9442
29 Samples
Download data: TXT
Series
Accession:
GSE56354
ID:
200056354
6.

miR-28 expression in the Burkitt lymphoma cell line P3HR1

(Submitter supplied) Burkitt lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma (B-NHL), which originates from germinal center (GC) B cells and harbors translocations deregulating the MYC oncogene. A comparative analysis of microRNAs (miRNAs) expressed in normal and malignant GC B cells identified miR-28 as significantly down-regulated in BL, as well as in other GC-derived B-NHL. We show that re-expression of miR-28 impairs cell growth and clonogenic properties of BL cells by modulating several targets including MAD2L1, a component of the spindle checkpoint whose down-regulation is essential in mediating miR-28-induced growth-arrest, and BAG1, an activator of the ERK pathway.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS5298
Platform:
GPL570
24 Samples
Download data: CEL, CHP
Series
Accession:
GSE56268
ID:
200056268
7.
Full record GDS5298

miR-28 expression effect on Burkitt lymphoma cell line: time course

Analysis of P3HR1 Burkitt lymphoma (BL) cells expressing miR-28 for 12 and 24 hours. BL is a highly aggressive B-cell non-Hodgkin lymphoma. miR-28 is downregulated in BL. Results provide insight into the role of miR-28 in the pathogenesis of BL.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 protocol, 2 time sets
Platform:
GPL570
Series:
GSE56268
24 Samples
Download data: CEL, CHP
8.

Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics

(Submitter supplied) Burkitt lymphoma (BL) can often be cured by intensive chemotherapy, but the toxicity of such therapy precludes its use in the elderly and in patients with endemic BL (eBL) in developing countries, necessitating new strategies. The normal germinal center B cell is the presumed cell of origin for both BL and diffuse large B cell lymphoma (DLBCL), yet gene expression analysis suggests that these malignancies may utilize different oncogenic pathways. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
32 Samples
Download data: TXT
Series
Accession:
GSE35163
ID:
200035163
9.

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

(Submitter supplied) In Burkitt lymphoma (BL), an aggressive germinal-center (GC) derived non-Hodgkin B-cell lymphoma characterized by MYC translocations as early transforming event, the apoptotic properties of MYC must have been overcome by pro-survival signals. Whereas activation of the pro-survival factor NFkappaB is not eminent in BL, PI3K signalling, which mediates B cell receptor associated survival signals in mature B cells, might be the cooperating event. more...
Organism:
Mus musculus
Type:
Expression profiling by array; Genome variation profiling by SNP array
Platforms:
GPL1261 GPL13147
13 Samples
Download data: CEL
Series
Accession:
GSE35219
ID:
200035219
10.

miRNA expression in thyroid cancer cells

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Non-coding RNA profiling by array
Platforms:
GPL4717 GPL1456
12 Samples
Download data: GPR
Series
Accession:
GSE20083
ID:
200020083
11.

Effect of histone deacetylase inhibitors on miRNA expression in thyroid cancer cells

(Submitter supplied) BCPAP papillary thyroid carcinoma cells were cultured in the presence or the absence of TSA (330nM) for 16h in fresh complete medium. Three independent experiments were performed and total RNA was extracted.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL4717
6 Samples
Download data: GPR
Series
Accession:
GSE19934
ID:
200019934
12.

Overexpression of miR-129-5p in thyroid carcinoma cells

(Submitter supplied) TCP1 papillary thyroid carcinoma cells were plated at 100,000 cells/well in a 6-well plate and transfected with 10nM of a synthetic pre-miR-129-5p or a negative pre-miRNA using Lipofectamine RNAiMAX reagent. RNA samples were harvested at 24 and 48 hours post-transfection.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL1456
6 Samples
Download data: GPR
Series
Accession:
GSE19933
ID:
200019933
13.

Deep sequencing of MYC DNA-binding sites in Burkitt's lymphoma

(Submitter supplied) Background: MYC is a transcription factor encoded by the c-MYC gene (thereafter termed MYC). MYC is key transcription factor involved in many central cellular processes including ribosomal biogenesis. MYC is overexpressed in the majority of human tumours including aggressive B-cell lymphoma especially Burkitt's lymphoma. Although Burkitt's lymphoma is a highlight example for MYC overexpression due to a chromosomal translocation, no global analysis of MYC binding sites by chromatin immunoprecipitation (ChIP) followed by global next generation sequencing (ChIP-Seq) has been conducted so far in Burkitt's lymphoma. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by array
Platforms:
GPL96 GPL9052
22 Samples
Download data: BED, CEL, TXT
14.

circZDHHC11 knockdown in ST486 cells

(Submitter supplied) To determine the effect of circZDHHC11 knockdown on gene expression in burkitt lymphoma cell line ST486
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL21185
6 Samples
Download data: TXT
Series
Accession:
GSE252484
ID:
200252484
15.

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
24 Samples
Download data: TXT
Series
Accession:
GSE70939
ID:
200070939
16.

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [KM-H2]

(Submitter supplied) Several studies have indicated an important role for miR-155 in the pathogenesis of B-cell lymphoma. Highly elevated levels of miR-155 were indeed observed in most B-cell lymphomas with the exception of Burkitt lymphoma (BL). However, the molecular mechanisms that underlie the oncogenic role of miR-155 in B-cell lymphoma are not well understood. To identify the miR-155 targets relevant for B-cell lymphoma, we performed RNA immunoprecipitation of Argonaute 2 in Hodgkin lymphoma (HL) cells upon miR-155 inhibition and in BL cells upon ectopic expression of miR-155. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
8 Samples
Download data: TXT
Series
Accession:
GSE70938
ID:
200070938
17.

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [L1236]

(Submitter supplied) Several studies have indicated an important role for miR-155 in the pathogenesis of B-cell lymphoma. Highly elevated levels of miR-155 were indeed observed in most B-cell lymphomas with the exception of Burkitt lymphoma (BL). However, the molecular mechanisms that underlie the oncogenic role of miR-155 in B-cell lymphoma are not well understood. To identify the miR-155 targets relevant for B-cell lymphoma, we performed RNA immunoprecipitation of Argonaute 2 in Hodgkin lymphoma (HL) cells upon miR-155 inhibition and in BL cells upon ectopic expression of miR-155. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
8 Samples
Download data: TXT
Series
Accession:
GSE70937
ID:
200070937
18.

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [ST486]

(Submitter supplied) Several studies have indicated an important role for miR-155 in the pathogenesis of B-cell lymphoma. Highly elevated levels of miR-155 were indeed observed in most B-cell lymphomas with the exception of Burkitt lymphoma (BL). However, the molecular mechanisms that underlie the oncogenic role of miR-155 in B-cell lymphoma are not well understood. To identify the miR-155 targets relevant for B-cell lymphoma, we performed RNA immunoprecipitation of Argonaute 2 in Hodgkin lymphoma (HL) cells upon miR-155 inhibition and in BL cells upon ectopic expression of miR-155. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6480
8 Samples
Download data: TXT
Series
Accession:
GSE64484
ID:
200064484
19.

Microarray analysis to identify miRNA targetome of primary Burkitt lymphoma tumors in comparison to normal CD19+ B cells

(Submitter supplied) MicroRNAs (miRNAs) are small non-coding RNAs involved in the posttranscriptional regulation of gene expression. Deregulated miRNA levels have been reported in Burkitt lymphoma (BL) compared to normal B cells and a number of miRNA target genes have been identified in BL cell lines. Here, we determined for the first time the miRNA targetomes of primary BL tumors in comparison with normal B cells. AGO2-RNA immunoprecipitation (AGO2-RIP) in two frozen diagnostic BL tissue samples and three CD19+ B-cell samples isolated from routinely removed tonsils revealed distinct miRNA targetomes of BL and normal B cells. more...
Organism:
Homo sapiens
Type:
Other
Platform:
GPL18641
20 Samples
Download data: TXT
Series
Accession:
GSE107325
ID:
200107325
20.

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response

(Submitter supplied) investigate the pre-clinical activities of two novel histone deacetylase inhibitors (HDACi), ITF-A and ITF-B, in a large panel of pre-clinical lymphoma models
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
24 Samples
Download data: TXT
Series
Accession:
GSE64821
ID:
200064821
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_674b0a4e2b399b623838eff4|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center